Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 1
1971 2
1977 1
1990 1
1992 1
1997 1
1998 2
1999 5
2000 5
2001 4
2002 2
2003 5
2004 5
2005 5
2006 10
2007 3
2008 3
2009 9
2010 12
2011 4
2012 5
2013 6
2014 5
2015 6
2016 7
2017 14
2018 13
2019 21
2020 13
2021 11
2022 2
2023 4
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

158 results

Results by year

Filters applied: . Clear all
Page 1
Effects of caffeine on sleep quality and daytime functioning.
O'Callaghan F, Muurlink O, Reid N. O'Callaghan F, et al. Risk Manag Healthc Policy. 2018 Dec 7;11:263-271. doi: 10.2147/RMHP.S156404. eCollection 2018. Risk Manag Healthc Policy. 2018. PMID: 30573997 Free PMC article. Review.
Foreword.
O'Callaghan F. O'Callaghan F. Dev Med Child Neurol. 2021 Jan;63 Suppl 1:3. doi: 10.1111/dmcn.14771. Dev Med Child Neurol. 2021. PMID: 33378088 Free article. No abstract available.
Add-on Cannabidiol Treatment for Drug-Resistant Seizures in Tuberous Sclerosis Complex: A Placebo-Controlled Randomized Clinical Trial.
Thiele EA, Bebin EM, Bhathal H, Jansen FE, Kotulska K, Lawson JA, O'Callaghan FJ, Wong M, Sahebkar F, Checketts D, Knappertz V; GWPCARE6 Study Group. Thiele EA, et al. Among authors: o callaghan fj. JAMA Neurol. 2021 Mar 1;78(3):285-292. doi: 10.1001/jamaneurol.2020.4607. JAMA Neurol. 2021. PMID: 33346789 Free PMC article. Clinical Trial.
Safety and effectiveness of hormonal treatment versus hormonal treatment with vigabatrin for infantile spasms (ICISS): a randomised, multicentre, open-label trial.
O'Callaghan FJ, Edwards SW, Alber FD, Hancock E, Johnson AL, Kennedy CR, Likeman M, Lux AL, Mackay M, Mallick AA, Newton RW, Nolan M, Pressler R, Rating D, Schmitt B, Verity CM, Osborne JP; participating investigators. O'Callaghan FJ, et al. Lancet Neurol. 2017 Jan;16(1):33-42. doi: 10.1016/S1474-4422(16)30294-0. Epub 2016 Nov 10. Lancet Neurol. 2017. PMID: 27838190 Free article. Clinical Trial.
Epilepsy and cannabis: so near, yet so far.
Kirkpatrick M, O'callaghan F. Kirkpatrick M, et al. Among authors: o callaghan f. Dev Med Child Neurol. 2022 Feb;64(2):162-167. doi: 10.1111/dmcn.15032. Epub 2021 Sep 8. Dev Med Child Neurol. 2022. PMID: 34498262 Free article. Review.
The United Kingdom Infantile Spasms Study (UKISS) comparing hormone treatment with vigabatrin on developmental and epilepsy outcomes to age 14 months: a multicentre randomised trial.
Lux AL, Edwards SW, Hancock E, Johnson AL, Kennedy CR, Newton RW, O'Callaghan FJ, Verity CM, Osborne JP; United Kingdom Infantile Spasms Study. Lux AL, et al. Among authors: o callaghan fj. Lancet Neurol. 2005 Nov;4(11):712-7. doi: 10.1016/S1474-4422(05)70199-X. Lancet Neurol. 2005. PMID: 16239177 Clinical Trial.
Tuberous sclerosis.
O'Callaghan FJ. O'Callaghan FJ. BMJ. 1999 Apr 17;318(7190):1019-20. doi: 10.1136/bmj.318.7190.1019. BMJ. 1999. PMID: 10205080 Free PMC article. No abstract available.
Toward responsible clinical n-of-1 strategies for rare diseases.
Defelippe VM, J M W van Thiel G, Otte WM, Schutgens REG, Stunnenberg B, Cross HJ, O'Callaghan F, De Giorgis V, Jansen FE, Perucca E, Brilstra EH, Braun KPJ. Defelippe VM, et al. Among authors: o callaghan f. Drug Discov Today. 2023 Oct;28(10):103688. doi: 10.1016/j.drudis.2023.103688. Epub 2023 Jun 24. Drug Discov Today. 2023. PMID: 37356616 Free article. Review.
158 results